Odonate Therapeutics, Inc. ODT
$ 1.52
-3.18%
Odonate Therapeutics, Inc. Income Statement 2011-2024 | ODT
Annual Income Statement Odonate Therapeutics, Inc.
2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
759 M | 812 M | 398 M | 301 M | - | - | - | - | - | - |
Shares |
32.8 M | 27.6 M | 24.5 M | 14.2 M | - | - | - | - | - | - |
Net Income |
-126 M | -112 M | -89 M | -32.7 M | -3.08 M | -158 K | - | - | - | - |
Revenue |
- | - | - | - | - | - | - | - | - | - |
EBITDA |
-127 M | -115 M | -90.4 M | -32.7 M | -3.08 M | -158 K | - | - | - | - |
Operating Expenses |
127 M | 115 M | 90.8 M | - | - | - | - | - | - | - |
General and Administrative Expenses |
10.4 M | 10.9 M | 10.8 M | 4.84 M | 463 K | 158 K | - | - | - | - |
All numbers in USD currency